<div id="readability-page-1"><p>In a report released on December 16, Caitlin Roberts from Canaccord Genuity maintained a Buy rating on OrthoPediatrics, with a price target of <span id="expert-recommendation-target">$24.00</span>.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>According to TipRanks, Roberts is a 2-star analyst with an average return of <span>-0.9%</span> and a 33.33% success rate. Roberts covers the Healthcare sector, focusing on stocks such as Smith &amp; Nephew Snats, AxoGen, and OrthoPediatrics.</p> <p>The word on The Street in general, suggests a Strong Buy analyst consensus rating for OrthoPediatrics with a $24.00 average price target.</p></div>

KIDS

<p>Canaccord Genuity's Caitlin Roberts maintains a Buy rating on OrthoPediatrics (KIDS) with a $24.00 price target. Roberts, a 2-star analyst, has an average return of -0.9% and a 33.33% success rate. The consensus among analysts is a Strong Buy for OrthoPediatrics, with a $24.00 average price target.</p>

Canaccord Genuity Keeps Their Buy Rating on OrthoPediatrics (KIDS)